The number of red blood cells that produce the abnormal hemoglobin S (HbS), which characterizes sickle cell disease (SCD),…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Point-of-care tests can be used to accurately diagnose sickle cell disease (SCD) in resource-limited settings such as sub-Saharan Africa,…
HPC International has released new editions of Hope & Destiny, a book series that aims to help people with sickle…
The U.S. Food and Drug Administration (FDA) has lifted its clinical hold on FTX-6058, an investigational oral treatment for…
A gene editing technology called adenosine base editing (ABE), wherein a single DNA building block is changed to increase fetal…
The fourth annual Cheek Week, an effort to include more blood stem cell donors in the Be The Match…
The U.S. Food and Drug Administration (FDA) is expected to decide before year’s end on whether or not to approve…
The Committee for Medicinal Products for Human Use (CHMP) is recommending the conditional approval of Adakveo (crizanlizumab) for…
The 5th annual Kier’s Hope 5K Run and Fun Walk — a fundraiser launched by comedian Kier “Junior” Spates…
Hillhurst Biopharmaceuticals announced that the final healthy volunteer has completed the study protocol in a Phase 1 clinical trial…